Loading clinical trials...
Loading clinical trials...
A Phase 2 Study of Biomarker-Modulated PSMA Theranostics
Conditions
Interventions
Biospecimen Collection
Bone Scan
+6 more
Locations
3
United States
University of California San Francisco
San Francisco, California, United States
Olive View-University of California Los Angeles Medical Center
Sylmar, California, United States
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Start Date
April 29, 2025
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2027
Last Updated
March 24, 2026
NCT04693377
NCT06705686
NCT06305598
NCT04489719
NCT06470243
NCT05053152
Lead Sponsor
University of Washington
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions